News - NLSDays - NLSDays

Latest news in cooperation with Nordic Life Science

Exploring links between endothelial cell function and metabolism

20 November 2019 | 2:50 pm

Sarah McGarrity’s research focuses on endothelial cells, which are important for blood pressure and clotting, and her findings might give us a better understanding and lead to treatments for conditions including cardiovascular disease, diabetic vascular damage and acute vascular problems due to shock. McGarrity, PhD, was one of the recipients of the Novo Nordisk Foundation’s […]

Zelluna Immunotherapy and Glycostem Therapeutics announce collaboration agreement

19 November 2019 | 12:20 pm

Zelluna Immunotherapy and Glycostem Therapeutics have announce that they have entered into a development, license and supply agreement. This collaboration will focus on the development and manufacture of allogeneic TCR guided NK-cell therapies (TCR-NK’s) for the treatment of patients with cancer. “This partnership between Zelluna and Glycostem represents a critical milestone in Zelluna’s aim to […]

Nikolaj Sørensen – In a business state of mind

19 November 2019 | 10:28 am

Business has been on Nikolaj Sørensen’s mind from an early age. Today, his leadership skills ranks high in employee surveys and he has been on a journey not many Nordic life science CEOs have experienced, taking a small company from Sweden to the big U.S. market and tackling the big problem of opioid addiction. During […]

UmanDiagnostics signs agreement with Siemens

19 November 2019 | 7:52 am

UmanDiagnostics has signed a new licensing and supply agreement with global giant Siemens. “Siemens is a world leader in our industry, so this is an extremely important agreement for us,” says Niklas Norgren, CEO of UmanDiagnostics. Acquired by Quanterix This summer UmanDiagnostics was purchased by major US life science company Quanterix for $22,5 million, and […]

Lithium can reverse radiation damage after brain tumour treatment

18 November 2019 | 9:55 am

Researchers at Karolinska Institutet have shown that the memory capacity and learning capability of mice improve if lithium treatment is given after the irradiation of the brain. Mice that were irradiated early in life and then given lithium from adolescence until young adulthood performed just as well as mice who had not been given radiation. […]

AstraZeneca’s Qtrilmet approved in the EU for treatment of type-2 diabetes

18 November 2019 | 9:46 am

The European Commission (EC) has approved Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets to improve glycaemic control in adults with type-2 diabetes (T2D). The approval is based on data from five Phase III trials which evaluated combinations of Forxiga (dapagliflozin) and Onglyza (saxagliptin) on a background of metformin in patients with inadequately controlled T2D. The primary endpoint in […]

Recipharm offers to acquire Consort Medical

18 November 2019 | 9:40 am

Recipharm and Consort Medical have reached an agreement on the terms of a recommended cash offer by Recipharm Holdings Limited, a wholly-owned direct subsidiary of Recipharm, for Consort. The Board of Consort has confirmed its unanimous intention to recommend a cash offer for an equity value of GBP 505 million (approximately SEK 6,284 million). Consort […]

MetaCurUm Biotech appoints new CEO

15 November 2019 | 8:05 am

MetaCurUm Biotech has appointed Lotta Berg as its new CEO. Berg officially started her new position in the company in October. “To contribute to the development of a new cancer treatment is both exciting and valuable,” she says. A spinn-off from Umeå University MetaCurUm Biotech develops a new treatment of aggressive cancer. The company is […]

Science Q&A: Combating insulin resistance

13 November 2019 | 12:43 pm

Kaja Plucinska’s research focuses on the brown and beige fat secretome and the discovery of novel endocrine factors regulating insulin sensitivity and energy balance. Her findings might lead to new therapeutic strategies to combat insulin resistance in Type 2 Diabetes. Kaja Plucinska, PhD, was one of the recipients of the Novo Nordisk Foundation’s postdoctoral fellowships […]

Bonesupport announces changes in its leadership team

13 November 2019 | 9:01 am

Bonesupport announces changes in its leadership team that will take place November 18, 2019. The company appoints Fergus MacLeod as General Manager and EVP Commerical Operations EUROW. MacLeod has more than 20 years of experience from international sales leadership positions within the Orthobiologics and Medical Devices sectors at companies like Johnson Matthey, RTI Surgical and […]

Latest news in cooperation with Nordic Life Science

Exploring links between endothelial cell function and metabolism

Zelluna Immunotherapy and Glycostem Therapeutics announce collaboration agreement

Nikolaj Sørensen – In a business state of mind

UmanDiagnostics signs agreement with Siemens

Lithium can reverse radiation damage after brain tumour treatment

AstraZeneca’s Qtrilmet approved in the EU for treatment of type-2 diabetes

Recipharm offers to acquire Consort Medical

MetaCurUm Biotech appoints new CEO

Science Q&A: Combating insulin resistance

Bonesupport announces changes in its leadership team

Join the conference!

Join the conference!

© 2019 Bionordic. All Rights Reserved
Legal Notices

Latest news in cooperation with Nordic Life Science

Join the conference!

© 2019 Bionordic. All Rights ReservedLegal Notices

© 2019 Bionordic. All Rights Reserved
Legal Notices